close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

LLY

1,021.52

+0.37%↑

JNJ

195.34

+0.5%↑

ABBV

232.46

-0.34%↓

UNH

332.18

-2.03%↓

AZN

88.54

+0.99%↑

Strona główna・Stock List・Nektar Therapeutics
Search

Nektar Therapeutics

Closed

53.96 -6.16

Buy

Price update 13 lis 2025, 20:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

52.98

Max

57.71

Key metrics

By Trading Economics

Income

6.1M

-36M

Sales

615K

12M

EPS

-1.868

Profit margin

-301.289

Employees

61

EBITDA

4.6M

-32M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+62.75% upside

Market Stats

By TradingEconomics

Market Cap

-37M

1.1B

Previous open

60.12

Previous close

53.96

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

0.5949 / 0.7406 Support & Resistance

Nektar Therapeutics Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

12 lis 2025, 21:55 UTC

Earnings

Xero Beats 1st Half Profit Expectations Despite Melio Margin Hit

DJ

Read

12 lis 2025, 21:34 UTC

Earnings

Cisco Systems Boosts Fiscal Year Outlook as 1Q Profit, Revenue Rise

DJ

Read

12 lis 2025, 23:44 UTC

Market Talk

Nikkei May Trade in Range Amid Caution Over U.S. Econ -- Market Talk

DJ

Read

12 lis 2025, 23:38 UTC

Market Talk

Gold Steady Ahead of Expected End to U.S. Government Shutdown -- Market Talk

DJ

Read

12 lis 2025, 23:13 UTC

Earnings

Samsung Fire & Marine Insurance 3Q Net Profit Largely Met FactSet-Compiled Consensus

DJ

Read

12 lis 2025, 23:13 UTC

Earnings

Samsung Fire & Marine Insurance 3Q Net KRW538.50B Vs. Net KRW554.56B >000810.SE

DJ

Read

12 lis 2025, 23:13 UTC

Earnings

Samsung Fire & Marine Insurance 3Q Oper Pft KRW664.06B Vs. Pft KRW717.46B >000810.SE

DJ

Read

12 lis 2025, 23:13 UTC

Earnings

Samsung Fire & Marine Insurance 3Q Rev KRW5.732T Vs. KRW5.326T >000810.SE

DJ

Read

12 lis 2025, 22:30 UTC

Market Talk
Earnings

Firefly Aerospace Sets Plan for Next Launch After Explosion -- Market Talk

DJ

Read

12 lis 2025, 22:18 UTC

Earnings

Cisco Systems Boosts Outlook on AI-Driven Demand -- Update

DJ

Read

12 lis 2025, 22:12 UTC

Market Talk

Bank of Canada Rate Hikes Could Start in 2H 2026 -- Market Talk

DJ

Read

12 lis 2025, 22:05 UTC

Earnings

Pan American Silver: Campbell Succeeded Steve Busby >PAAS

DJ

Read

12 lis 2025, 22:04 UTC

Earnings

Pan American Silver Named Scott Campbell as Operating Chief on Oct. 20

DJ

Read

12 lis 2025, 22:04 UTC

Earnings

Pan American Silver 3Q Adj EPS 48c >PAAS

DJ

Read

12 lis 2025, 22:04 UTC

Earnings

Pan American Silver 3Q Rev $884.4M >PAAS

DJ

Read

12 lis 2025, 22:04 UTC

Earnings

Pan American Silver 3Q EPS 45c >PAAS

DJ

Read

12 lis 2025, 22:03 UTC

Earnings

Manulife Financial: 3Q Book Value Per Common Shr C$26.07 >MFC.T

DJ

Read

12 lis 2025, 22:02 UTC

Earnings

Manulife Financial 3Q Net C$1.8B >MFC

DJ

Read

12 lis 2025, 22:02 UTC

Earnings

Manulife Financial 3Q Adj EPS C$1.16 >MFC

DJ

Read

12 lis 2025, 22:02 UTC

Earnings

Manulife Financial 3Q EPS C$1.02 >MFC

DJ

Read

12 lis 2025, 21:53 UTC

Acquisitions, Mergers, Takeovers

BlueScope Steel: Sale Strengthens Focus on Own Growth Investments

DJ

Read

12 lis 2025, 21:53 UTC

Acquisitions, Mergers, Takeovers

BlueScope Steel Says Deal Subject to Indian Regulatory Approvals

DJ

Read

12 lis 2025, 21:53 UTC

Acquisitions, Mergers, Takeovers

BlueScope Steel Estimates Net Profit After Tax on Sale of A$70 Million

DJ

Read

12 lis 2025, 21:53 UTC

Acquisitions, Mergers, Takeovers

BlueScope Steel Expects Net Proceeds After Taxes, Fees of A$179 Million in 2H FY26

DJ

Read

12 lis 2025, 21:52 UTC

Acquisitions, Mergers, Takeovers

BlueScope Steel: Tata BlueScope Steel JV a Provider of Coated, Painted Steel Products in India

DJ

Read

12 lis 2025, 21:51 UTC

Acquisitions, Mergers, Takeovers

BlueScope Steel Agrees to Sell 50% Stake in Tata BlueScope Steel Joint Venture to Tata Steel

DJ

Read

12 lis 2025, 21:50 UTC

Market Talk
Earnings

Basic Materials Roundup: Market Talk

DJ

Read

12 lis 2025, 21:49 UTC

Earnings

Cisco Stock Climbs as Earnings Beat Expectations Amid Strong AI Demand -- Barrons.com

DJ

Read

12 lis 2025, 21:48 UTC

Earnings

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares. -- Barrons.com

DJ

Read

12 lis 2025, 21:40 UTC

Earnings

Xero Beats 1H Profit Expectations Despite Melio Margin Hit

DJ

Read

Peer Comparison

Price change

Nektar Therapeutics Forecast

Price Target

By TipRanks

62.75% upside

12 Months Forecast

Average 93.86 USD  62.75%

High 120 USD

Low 30 USD

Based on 8 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

6

Buy

1

Hold

1

Sell

Based on 8 analysts giving stock ratings to Nektar Therapeutics - Dist in the past 3 months.

Technical Score

By Trading Central

0.5949 / 0.7406Support & Resistance

Short Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

Bearish Evidence

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

1,021.52

↑ +0.37%

JNJ

Johnson and Johnson

195.34

↑ +0.5%

ABBV

AbbVie Inc

232.46

↓-0.34%

UNH

UnitedHealth Group Inc

332.18

↓-2.03%

AZN

AstraZeneca PLC ADR

88.54

↑ +0.99%
help-icon Live chat